Kezar Life Sciences (FRA:2KZ) Ending Cash Position : €30.39 Mil (As of Mar. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Kezar Life Sciences Ending Cash Position?

Kezar Life Sciences's Ending Cash Position for the quarter that ended in Mar. 2024 was €30.39 Mil.

Kezar Life Sciences's quarterly Ending Cash Position increased from Sep. 2023 (€24.83 Mil) to Dec. 2023 (€32.55 Mil) but then declined from Dec. 2023 (€32.55 Mil) to Mar. 2024 (€30.39 Mil).

Kezar Life Sciences's annual Ending Cash Position declined from Dec. 2021 (€55.65 Mil) to Dec. 2022 (€38.19 Mil) and declined from Dec. 2022 (€38.19 Mil) to Dec. 2023 (€32.55 Mil).

Kezar Life Sciences Ending Cash Position Historical Data

The historical data trend for Kezar Life Sciences's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kezar Life Sciences Ending Cash Position Chart

Kezar Life Sciences Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Ending Cash Position

Get a 7-Day Free Trial

13.46

17.45

55.65

38.19

32.55

Kezar Life Sciences Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Ending Cash Position	Get a 7-Day Free Trial															33.74	25.95	24.83	32.55	30.39

Kezar Life Sciences Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Kezar Life Sciences's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	37.098	+	-4.551
	=	32.55

Kezar Life Sciences's Ending Cash Position for the quarter that ended in Mar. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	32.653	+	-2.264
	=	30.39

Kezar Life Sciences Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Kezar Life Sciences's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Kezar Life Sciences (FRA:2KZ) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Kezar Life Sciences Inc (FRA:2KZ) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

KZR:USA 2KZ:Germany

Address

4000 Shoreline Court, Suite 300, South San Francisco, CA, USA, 94080

Website

https://www.kezarlifesciences.com

Kezar Life Sciences Inc is a clinical-stage biotechnology company. It is engaged in discovering and developing novel small molecule therapeutics to treat unmet needs in autoimmunity and cancer. The pipeline consist of product candidates such as KZR-616, and the protein secretion program.

Kezar Life Sciences (FRA:2KZ) Headlines

No Headlines